Vivalis is a Biopharmaceutical company based in France, which provides innovative solutions for the manufacture of vaccines and proteins.
In addition, Vivalis has a Viva|Screen Platform for the Discovery of Fully Human Antibodies isolated from Human B Lymphocytes extracted from the peripheral blood of a person using a high-throughput single cell screening methodology.
Using a microarray- based technology, the isolation of B Lymphocytes expressing Antibodies of interest, has now become more efficient, stable and reliable.